RT Journal Article
SR Electronic
T1 Evidence of Protective Effect of Hydroxychloroquine on COVID-19
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200638
DO 10.3899/jrheum.200638
A1 Beuy Joob
A1 Viroj Wiwanitkit
YR 2020
UL http://www.jrheum.org/content/early/2020/06/09/jrheum.200638.abstract
AB We would like to share ideas on the report “Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials”1. Balevic noted that “well-designed clinical trials that include patients with rheumatic disease are urgently needed to characterize the efficacy, safety, and target exposures for hydroxychloroquine1.”